RIPK2 and Stroke: There were no differences between groups in the longitudinal open field test total distance traveled (Fig. 2F); however, Ripk2-/- mice spent less time in the center of the open field arena than WT controls at baseline and days 1 and 3 post-stroke (Supplementary Fig. S1).